Published in CMAJ on March 25, 2008
Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study. JAMA Psychiatry (2015) 2.21
How applicable are clinical practice guidelines to elderly patients with comorbidities? Can Fam Physician (2011) 1.51
Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4). Can Geriatr J (2012) 1.39
Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord (2010) 1.24
Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease. CMAJ (2008) 1.21
Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ (2008) 1.13
Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia. CMAJ (2008) 1.08
MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study. BMJ Open (2013) 0.99
A review of barriers and enablers to diagnosis and management of persons with dementia in primary care. Can Geriatr J (2012) 0.98
Cobalamin deficiency, hyperhomocysteinemia, and dementia. Neuropsychiatr Dis Treat (2010) 0.94
The rural older adult memory (ROAM) study: a practice-based intervention to improve dementia screening and diagnosis. J Am Board Fam Med (2010) 0.93
Building capacity for dementia care: training program to develop primary care memory clinics. Can Fam Physician (2011) 0.92
Reducing pill burden and helping with medication awareness to improve adherence. Can Pharm J (Ott) (2013) 0.88
The emerging agenda of stratified medicine in neurology. Nat Rev Neurol (2013) 0.85
Frequency of dementia syndromes with a potentially treatable cause in geriatric in-patients: analysis of a 1-year interval. Eur Arch Psychiatry Clin Neurosci (2015) 0.82
Structured approach to patients with memory difficulties in family practice. Can Fam Physician (2013) 0.82
Persistence of cholinesterase inhibitor treatment in dementia: insights from a naturalistic study. Dement Geriatr Cogn Dis Extra (2013) 0.81
Association of blood cotinine level with cognitive and physical performance in non-smoking older adults. Environ Res (2012) 0.81
Vitamin B12 and cognitive function: an evidence-based analysis. Ont Health Technol Assess Ser (2013) 0.81
An update on the diagnosis and management of dementing conditions. Rev Neurol Dis (2011) 0.78
Cognitive assessments in multicultural populations using the Rowland Universal Dementia Assessment Scale: a systematic review and meta-analysis. CMAJ (2015) 0.77
Behaviour management in dementia. Can Fam Physician (2011) 0.77
Encountering aged care: a mixed methods investigation of medical students' clinical placement experiences. BMC Geriatr (2016) 0.77
Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients. BMC Geriatr (2015) 0.77
Improving the quality of life in patients with Alzheimer's disease. Psychiatry (Edgmont) (2008) 0.77
Diagnostic tools for alzheimer's disease dementia and other dementias: an overview of diagnostic test accuracy (DTA) systematic reviews. BMC Neurol (2014) 0.76
Increased masticatory activity and quality of life in elderly persons with dementia--a longitudinal matched cluster randomized single-blind multicenter intervention study. BMC Neurol (2013) 0.75
Kynurenines and other novel therapeutic strategies in the treatment of dementia. Ther Adv Neurol Disord (2013) 0.75
Understanding and optimizing brain health in HIV now: protocol for a longitudinal cohort study with multiple randomized controlled trials. BMC Neurol (2016) 0.75
Dementia: What pharmacists need to know. Can Pharm J (Ott) (2017) 0.75
Quality of Dementia Care in the Community: Identifying Key Quality Assurance Components. Can Geriatr J (2016) 0.75
Cognition, anesthesia, and surgery. Int Anesthesiol Clin (2014) 0.75
Alzheimer's disease with vascular component: a distinct clinical entity? Dement Geriatr Cogn Dis Extra (2012) 0.75
Progressive impairment of cognition and motor function: Hashimoto encephalopathy. CMAJ (2011) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Mild cognitive impairment: clinical characterization and outcome. Arch Neurol (1999) 33.06
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc (2005) 27.90
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry (1987) 19.45
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
The mini-mental state examination: a comprehensive review. J Am Geriatr Soc (1992) 15.32
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA (1997) 10.75
Delirium in older persons. N Engl J Med (2006) 9.70
Cerebral blood flow in dementia. Arch Neurol (1975) 9.24
CSF markers for incipient Alzheimer's disease. Lancet Neurol (2003) 6.12
Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol (1994) 5.20
Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA (2003) 4.16
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry (1992) 4.16
Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry (2000) 3.70
The AD8: a brief informant interview to detect dementia. Neurology (2005) 3.65
Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med (1995) 3.37
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging (2005) 3.32
Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology (2005) 3.03
The spectrum of behavioral changes in Alzheimer's disease. Neurology (1996) 2.97
DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry (2004) 2.91
Delirium in older people. BMJ (2007) 2.77
The reversible dementias: do they reverse? Ann Intern Med (1988) 2.46
A 7 minute neurocognitive screening battery highly sensitive to Alzheimer's disease. Arch Neurol (1998) 2.38
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study. Arch Gen Psychiatry (2004) 2.07
Screening for dementia and investigating its causes. Ann Intern Med (1991) 1.79
Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. CMAJ (2008) 1.70
The behavioural neurology assessment. Can J Neurol Sci (2005) 1.62
The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc (2002) 1.57
Delirium. J Neuropsychiatry Clin Neurosci (1993) 1.46
Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch Neurol (2001) 1.38
Behavioral symptoms in mild cognitive impairment. Neurology (2004) 1.36
Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. Arch Neurol (1994) 1.35
Canadian Consensus Conference on Dementia: a physician's guide to using the recommendations. CMAJ (1999) 1.34
The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. Can J Neurol Sci (2001) 1.27
Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. Am J Geriatr Psychiatry (2004) 1.24
Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J Neurol Sci (2004) 1.18
Undetected dementia in community-dwelling older people: the Canadian Study of Health and Aging. J Am Geriatr Soc (2000) 1.17
Neuropsychological testing and assessment for dementia. Alzheimers Dement (2007) 1.15
Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature. J Mol Neurosci (2004) 1.13
Do long tests yield a more accurate diagnosis of dementia than short tests? A comparison of 5 neuropsychological tests. Arch Neurol (1996) 1.11
Prevalence of potentially reversible dementias and actual reversibility in a memory clinic cohort. CMAJ (1998) 1.09
Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases. Brain (2003) 1.08
The clock drawing test is a poor screen for very mild dementia. Neurology (2002) 1.06
A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology (2003) 1.01
Assessment of suspected dementia. Can J Neurol Sci (2001) 0.97
Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord (1999) 0.94
Behavioral quantitation is more sensitive than cognitive testing in frontotemporal dementia. Alzheimer Dis Assoc Disord (2003) 0.93
Delirium as a disorder of consciousness. J Neurol Neurosurg Psychiatry (2007) 0.92
Amyloid beta protein in plasma as a diagnostic marker for Alzheimer's disease. Neurobiol Aging (1998) 0.89
Clinical diagnosis of dementia. Alzheimers Dement (2007) 0.87
Can you have dementia with an MMSE score of 30? Am J Alzheimers Dis Other Demen (2007) 0.86
Functional neuroimaging in the diagnosis of dementia. Alzheimers Dement (2007) 0.81
Structural neuroimaging in the diagnosis of dementia. Alzheimers Dement (2007) 0.80
Depression, dementia, and pseudodementia. Semin Clin Neuropsychiatry (2002) 0.79
Cobalamin and homocysteine in older adults: do we need to test for serum levels in the work-up of dementia? Alzheimers Dement (2007) 0.79
The role of biologic markers in the diagnosis of Alzheimer's disease. Alzheimers Dement (2007) 0.79
Neuropsychological test performance of specific diagnostic groups in the Canadian Study of Health and Aging (CSHA). J Clin Exp Neuropsychol (1995) 0.77
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc (2005) 27.90
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
Mild cognitive impairment. Lancet (2006) 10.21
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol (2007) 5.09
Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med (2004) 4.56
Mechanisms of action of arsenic trioxide. Cancer Res (2002) 3.68
The evolution and pathology of frontotemporal dementia. Brain (2005) 3.46
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative. Lancet Neurol (2007) 2.72
The cognitive profile of posterior cortical atrophy. Neurology (2006) 2.64
Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord (2007) 2.43
Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain (2008) 2.28
Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell (2007) 2.13
TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathol (2014) 1.90
Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease. Brain (2006) 1.88
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener (2013) 1.83
C9ORF72 repeat expansions in cases with previously identified pathogenic mutations. Neurology (2013) 1.70
Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. CMAJ (2008) 1.70
Predictors of driving cessation in mild-to-moderate dementia. CMAJ (2006) 1.68
Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease. Neuroimage (2008) 1.62
Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet (2011) 1.60
MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders. Curr Genomics (2009) 1.60
Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol Aging (2006) 1.57
Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging (2007) 1.47
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet (2012) 1.46
Validity of a novel computerized cognitive battery for mild cognitive impairment. BMC Geriatr (2003) 1.45
100 years after Alzheimer: contemporary neurology practice assessment of referrals for dementia. Am J Alzheimers Dis Other Demen (2008) 1.44
Cholinesterase inhibitors and Alzheimer's disease outcomes. J Gerontol A Biol Sci Med Sci (2007) 1.40
Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4). Can Geriatr J (2012) 1.39
The core and halo of primary progressive aphasia and semantic dementia. Ann Neurol (2003) 1.39
Gait assessment in mild cognitive impairment and Alzheimer's disease: the effect of dual-task challenges across the cognitive spectrum. Gait Posture (2011) 1.36
Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiol Aging (2012) 1.30
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharmacol (2006) 1.29
A longitudinal study of language decline in Alzheimer's disease and frontotemporal dementia. J Int Neuropsychol Soc (2007) 1.28
Oxysterols, cholesterol homeostasis, and Alzheimer disease. J Neurochem (2007) 1.26
Dual-tasking and gait in people with mild cognitive impairment. The effect of working memory. BMC Geriatr (2009) 1.25
The contribution of neuropsychiatric symptoms to the cost of dementia care. Int J Geriatr Psychiatry (2006) 1.24
A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease. J Am Geriatr Soc (2004) 1.22
Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease. J Alzheimers Dis (2009) 1.20
Amnestic MCI future clinical status prediction using baseline MRI features. Neurobiol Aging (2008) 1.16
Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia. CMAJ (2008) 1.15
Neuropsychological testing and assessment for dementia. Alzheimers Dement (2007) 1.15
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). Alzheimers Dement (2012) 1.14
Increased variability accompanies frontal lobe damage in dementia. J Int Neuropsychol Soc (2002) 1.13
Oxidative stress in diseases of the human cornea. Free Radic Biol Med (2008) 1.13
A longitudinal study of behavior in frontotemporal dementia and primary progressive aphasia. Cogn Behav Neurol (2004) 1.11
Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairment. Neuropsychology (2007) 1.11
Specialist physicians in geriatrics-report of the canadian geriatrics society physician resource work group. Can Geriatr J (2012) 1.09
The diagnosis and course of frontotemporal dementia. Alzheimer Dis Assoc Disord (2007) 1.08
Exploded drawing in posterior cortical atrophy. Neurology (2006) 1.08
Frontotemporal dementia: a review for primary care physicians. Am Fam Physician (2010) 1.08
Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia. CMAJ (2008) 1.08
Mild cognitive impairment. Am J Geriatr Psychiatry (2005) 1.03
A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Cancer Res (2009) 1.03
What is semantic dementia?: a cohort study of diagnostic features and clinical boundaries. Arch Neurol (2010) 1.02
General risk factors for dementia: a systematic evidence review. Alzheimers Dement (2007) 1.02
Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment. J Neuropathol Exp Neurol (2007) 1.01
Towards practical cognitive assessment for detection of early dementia: a 30-minute computerized battery discriminates as well as longer testing. Curr Alzheimer Res (2005) 1.01
HO-1-mediated macroautophagy: a mechanism for unregulated iron deposition in aging and degenerating neural tissues. J Neurochem (2009) 1.01
Cluster M mycobacteriophages Bongo, PegLeg, and Rey with unusually large repertoires of tRNA isotypes. J Virol (2013) 1.01
REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease. Sleep (2006) 1.00
Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study. J Neurol Sci (2006) 0.99
Magnetization transfer ratio in mild cognitive impairment and dementia of Alzheimer's type. Neuroimage (2002) 0.99
The effects of oxytocin on social cognition and behaviour in frontotemporal dementia. Brain (2011) 0.99
Computerized cognitive testing battery identifies mild cognitive impairment and mild dementia even in the presence of depressive symptoms. Am J Alzheimers Dis Other Demen (2006) 0.98
Canadian Outcomes Study in Dementia: study methods and patient characteristics. Can J Psychiatry (2004) 0.98
Unregulated brain iron deposition in transgenic mice over-expressing HMOX1 in the astrocytic compartment. J Neurochem (2012) 0.98
Over-expression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia. J Cell Physiol (2006) 0.97
The profile of executive functioning in amnestic mild cognitive impairment: disproportionate deficits in inhibitory control. J Int Neuropsychol Soc (2012) 0.97
Argyrophilic thorny astrocyte clusters in association with Alzheimer's disease pathology in possible primary progressive aphasia. Acta Neuropathol (2007) 0.97
The potential role of dopamine D₃ receptor neurotransmission in cognition. Eur Neuropsychopharmacol (2013) 0.97
Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development. Alzheimers Dement (2012) 0.96
A quantitative systematic review of domain-specific cognitive impairment in lacunar stroke. Neurology (2013) 0.96
Regional magnetization transfer ratio changes in mild cognitive impairment. Magn Reson Med (2002) 0.96
Corticobasal degeneration and progressive aphasia. Neurology (2006) 0.96
The prevalence of misidentification syndromes in neurodegenerative diseases. Alzheimer Dis Assoc Disord (2008) 0.95
Can cognitive enhancers reduce the risk of falls in people with dementia? An open-label study with controls. J Am Geriatr Soc (2009) 0.95
The nature of lexico-semantic processing deficits in mild cognitive impairment. Neuropsychologia (2006) 0.95
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95
Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias. Dement Geriatr Cogn Disord (2006) 0.95
Trolox selectively enhances arsenic-mediated oxidative stress and apoptosis in APL and other malignant cell lines. Blood (2004) 0.95
Differentiating the frontal variant of Alzheimer's disease. Int J Geriatr Psychiatry (2010) 0.94
Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma. Proteomics (2003) 0.94
Potential treatment effects of donepezil not detected in Alzheimer's disease clinical trials: a physician survey. Int J Geriatr Psychiatry (2004) 0.94
Where in-vivo imaging meets cytoarchitectonics: the relationship between cortical thickness and neuronal density measured with high-resolution [18F]flumazenil-PET. Neuroimage (2010) 0.94
Focused attention deficits in patients with Alzheimer's disease and mild cognitive impairment. Brain Cogn (2005) 0.93
Schizophrenia-like features in transgenic mice overexpressing human HO-1 in the astrocytic compartment. J Neurosci (2012) 0.93
Neuropsychiatric symptom clusters and functional disability in cognitively-impaired-not-demented individuals. Am J Geriatr Psychiatry (2007) 0.93
Validity of the Mindstreams computerized cognitive battery for mild cognitive impairment. J Mol Neurosci (2004) 0.93